Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Heron Therapeutics Inc (NASDAQ:HRTX)

18.48
Delayed Data
As of Feb 10
 -0.28 / -1.49%
Today’s Change
8.93
Today|||52-Week Range
42.25
-30.79%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2011

2012

2013

2014
Revenue and IncomeNet Revenues646.0K0.000.000.00
 
 
Depreciation And Amortization179.0K197.0K333.0K578.0K
 
 
 
 
 
 
Operating ExpensesGross Income-----333.0K-578.0K
 
 
 
General Expenses11.5M23.6M54.1M74.0M
 
 
 
 
 
Research And Development8.2M15.0M32.8M54.8M
 
 
 
 
 
Total Operating Expenses11.7M23.8M54.5M74.6M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-11.1M-23.8M-54.5M-74.6M
 
 
 
 
 
Interest Expense On Debt373.0K599.0K826.0K887.0K
 
 
 
 
 
Other Expenses0.000.000.00-919.0K
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-11.4M-24.4M-55.3M-76.4M
 
 
 
 
 
Discontinued Operations-379.0K1.1M0.000.00
 
 
 
Net Income-11.8M-23.3M-55.3M-76.4M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS6.0M12.2M16.2M26.6M
 
 
 
 
 
Shares To Calculate EPS Diluted6.0M12.2M16.2M26.6M
 
 
 
 
 
 
Earnings Per ShareEPS-$2.00-$2.00-$3.42-$2.87
 
 
 
 
 
EPS Diluted-$2.00-$2.00-$3.42-$2.87